Drug intelligence / Profile preview

GT-GBA1-S05

Development stage
Preclinical
Lead developer
Glafabra Therapeutics
Modality
Gene Therapies, Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

GT-GBA1-S05 is a preclinical ex vivo hematopoietic stem cell gene therapy being developed by Glafabra Therapeutics for the treatment of Gaucher disease. Utilizing the proprietary Live-cel platform, the therapy involves harvesting a patient's own hematopoietic stem cells and genetically modifying them using lentiviral vectors to carry a functional copy of the GBA1 gene. Once reinfused, these engineered cells engraft in the bone marrow and differentiate into various blood cell lineages that provide a continuous source of the glucocerebrosidase (GBA) enzyme throughout the body via a mechanism known as cross-correction. This one-time treatment is designed to restore enzyme activity and provide a durable therapeutic alternative to traditional enzyme replacement therapy.

Other names
GT-GLA (Gaucher program)

Beyond the preview

Go deeper on GT-GBA1-S05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GT-GBA1-S05.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call